Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Moe Thi Thi HanDivision of Clinical Chemistry, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.
Tarika ThumvijitDepartment of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.
Kanyamas ChoocheepDivision of Clinical Chemistry, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.
Warunee KumsaiyaiDivision of Clinical Chemistry, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.ORCID 0009-0008-8254-4234
Yupanun WuttiinCancer Research Unit, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.ORCID 0000-0002-6402-7195
Khanittha PuntureeDivision of Clinical Chemistry, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.ORCID 0000-0003-2506-8530
Sakorn PornprasertDivision of Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.
Sawitree ChiampanichayakulCancer Research Unit, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.
Ratchada CresseyDivision of Clinical Chemistry, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai 50200, Thailand.ORCID 0000-0003-4346-4422
Funding
Chiang Mai University CMU Presidential ScholarshipFundamental Fund 2024, Chiang Mai University 195943_FF083/2567
6 · The paper itself
Abstract
Residential radon is a leading environmental cause of lung cancer, but circulating biomarkers linking home exposure to pathogenic biology are not well defined. We conducted an exposure-contrast study in Hang Dong District, Chiang Mai, measuring indoor radon in 48 homes and enrolling adults from <50 Bq/m
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Serum miRNA and Metabolomic Signatures of Residential Radon Exposure in Chiang Mai, Thailand. · full record | OpenQuestion